External Validation of Delirium Prediction Models for Intensive Care Patients
NCT ID: NCT05084482
Last Updated: 2025-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
660 participants
OBSERVATIONAL
2022-01-01
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Delirium at the Intensive Care Unit - a Retrospective Cohort Study
NCT02603731
Validating a Delirium Prediction Model for Critically Ill Patients
NCT00961389
DANish DELIrium Study On Neurointensive Care Patients
NCT02594982
Incidence of Delirium in Critically Ill Patients in a Dutch University Hospital
NCT00604773
The ICU DElirium in Clinical PracTice Implementation Evaluation Study Screening and Treatment
NCT01952899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Eligible patients will be assessed with E-PREDELIRIC at admission to the ICU and PREDELIRIC 24h after admission to the ICU. Patients will be screened twice daily with CAM-ICU until ICU discharge, death, transferal to non-participating ICU or for a maximum observation period of 14 days.
Central screening via EPIC PDM and registration in central database (REDCap, ZUH) by the principal investigator.
The following are registered: Age, sex, history of cognitive impairment, history of alcohol abuse, admission category, urgent admission, mean arterial blood pressure at the time of ICU admission, use of corticosteroids, respiratory failure, Blood Urea Nitrogen/Carbamide, APACHE-II score, administered morphine does, use of sedatives, metabolic acidosis, coma, presence of infection, delirium status by CAM-ICU, time of ventilation, length of ICU and hospital stay, mortality.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adult patients admitted to Intensive Care Unit (ICU)
Eligible patients are scored by E-PRE-DELIRIC at admission and PRE-DELIRIC 24 hours after admission.
Prediction models
The prediction scores are validated by the CAM-ICU scores up to 14 days after ICU admission.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prediction models
The prediction scores are validated by the CAM-ICU scores up to 14 days after ICU admission.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 of years
Exclusion Criteria
* Delirium assessment nonapplicable (hearing or visual disabilities, language barriers, or mentally incompetent
18 Years
110 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zealand University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lone Musaeus Poulsen
Head of ICU
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neeliya Anton Joseph, BSc Medicine
Role: PRINCIPAL_INVESTIGATOR
Department of Anaesthesiology, Zealand University Hospital, Køge, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zealand University Hospital, Department of Anaesthesiology
Køge, Zealand Region of Denmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZUH.01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.